
Metsep P 1mg/500mg/15mg Tablet SR
Marketer
Sepik Life Sciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metsep P 1mg/500mg/15mg Tablet SR
Metsep P 1mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. This regimen, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, reducing blood sugar. Dosage and duration for Metsep P should strictly adhere to your physician's instructions. Take with food to prevent gastrointestinal distress. Missed doses should be taken promptly unless nearing the next scheduled dose; in that case, omit the missed dose and resume your normal schedule. Never double the dose; overdose can cause hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be performed before treatment initiation. Limit alcohol consumption as it can exacerbate side effects.
Primary Ingredients of Metsep P 1mg/500mg/15mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Metsep P 1mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Metsep P 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Metsep P 1mg/500mg/15mg Extended-Release tablets with food.
Common Side effects of Metsep P 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metsep P 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metsep P 1mg/500mg/15mg Tablet SR whole; do not break, crush, or chew it. Administer this extended-release tablet with a meal.
How Metsep P 1mg/500mg/15mg Tablet SR works:
Metsep P SR tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Pioglitazone, a thiazolidinedione, further boosts insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Metsep P 1mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Metsep P 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Metsep P tablets (1mg/500mg/15mg) are likely unsuitable for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Metsep P 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Metsep P 1mg/500mg/15mg SR tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Metsep P 1mg/500mg/15mg SR tablets. Dosage modification of Metsep P 1mg/500mg/15mg SR tablets may be necessary. Physician consultation is advised. Metsep P 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe liver disease.
What if you forget to take Metsep P 1mg/500mg/15mg Tablet SR :
Should you forget a Metsep P 1mg/500mg/15mg SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metsep P 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
